Earnings Summary

Blackrock Health Sciences Trust’s revenue fell -20.41% since last year same period to $16.61Mn in the Q2 2023. On a quarterly growth basis, Blackrock Health Sciences Trust has generated 680.01% jump in its revenue since last 3-months.

Blackrock Health Sciences Trust’s net profit jumped 118.16% since last year same period to $11.31Mn in the Q2 2023. On a quarterly growth basis, Blackrock Health Sciences Trust has generated 100% jump in its net profits since last 3-months.

Blackrock Health Sciences Trust’s net profit margin jumped 122.82% since last year same period to 68.11% in the Q2 2023. On a quarterly growth basis, Blackrock Health Sciences Trust has generated -74.36% fall in its net profit margins since last 3-months.

Blackrock Health Sciences Trust’s earning per share (EPS) estimates for the current year stand at 0.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Blackrock Health Sciences Trust’s return on assets (ROA) stands at 0.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Blackrock Health Sciences Trust’s return on equity (ROE) stands at 0.03.

Blackrock Health Sciences Trust declared 0.64 dividend per share during the earnings announcement for Q4 2023.